Lenalidomide capsule 2.5mg “BMSH” by Bristol-Myers Squibb Sales contains Lenalidomide hydrate, used for conditions including multiple myeloma, myelodysplastic syndromes, follicular lymphoma, and mantle cell lymphoma. This 2.5mg 1 capsule formulation is identified by YJ code 4291024M2039.
Lenalidomide capsule 2.5mg “BMSH”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
